MicroRNA Discovery Clinches Nobel for Ambros and Ruvkun

Americans Victor Ambros and Gary Ruvkun won the Nobel Prize in medicine for uncovering microRNA's role in gene regulation, a vital biological process. The duo, affiliated with esteemed academic institutions in Massachusetts, join a prestigious roster of laureates receiving recognition in this year's Nobel Prize series.

Americans Victor Ambros and Gary Ruvkun have been awarded the Nobel Prize in medicine for their groundbreaking discovery of microRNA, which plays a crucial role in gene regulation. The Nobel Assembly praised this discovery as a significant finding that is essential for understanding organism development and function.

Ambros conducted his prize-winning research at Harvard University and is now a professor at the University of Massachusetts Medical School. Ruvkun carried out his research at Massachusetts General Hospital and Harvard Medical School, where he is a professor of genetics. The announcement of their achievement was made by Thomas Perlmann, Secretary-General of the Nobel Committee.

Katalin Karikó and Drew Weissman received last year's Nobel Prize for their work on mRNA vaccines crucial in combating COVID-19. This year's Nobel Prize carries a monetary reward of 11 million Swedish kronor ($1 million), continuing the tradition established by Alfred Nobel. The Nobel award ceremonies will take place on December 10.

(With inputs from agencies.)